Search research articles
Contact Us
Filters
Showing results (31-40 of 117) with videos related to
Page
of 12
Sort By:
Bibliotheca Haematologica
|
January 1, 1973
Pharmacologic and cytokinetic studies of arabinosyl cytosine
E Frei, D H Ho, G P Bodey, et al.
Cancer Chemotherapy Reports
|
December 1, 1971
Distribution and mechanism of clearance of L-asparaginase (NSC-109229)
D H Ho, C J Carter, B Thetford, et al.
European Journal of Clinical Microbiology
|
August 1, 1986
Activity of newer antimicrobial agents against Aeromonas hydrophila
K V Rolston, D H Ho, B LeBlanc, et al.
Cancer Research
|
February 1, 1970
L-asparagine requirement and the effect of L-asparaginase on the normal and leukemic human bone marrow
D H Ho, J P Whitecar, J K Luce, et al.
The Journal of Antimicrobial Chemotherapy
|
July 1, 1990
In-vitro activity of PD 117 596, a new quinolone, against bacterial isolates from cancer patients
K V Rolston, B LeBlanc, D H Ho, et al.
Anticancer Research
|
July 1, 1986
Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate
D H Ho, L Townsend, M A Luna, et al.
Cancer Chemotherapy Reports
|
February 1, 1971
Azotomycin (NSC-56654): biologic fate in mice and man
R F Pittillo, C Woolley, R W Brockman, et al.
Chemotherapy
|
January 1, 1987
In vitro evaluation of difloxacin (A-56619), A-56620, and other 4-quinolones against isolates from cancer patients
K V Rolston, D H Ho, B LeBlanc, et al.
Antimicrobial Agents and Chemotherapy
|
January 1, 1987
In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients
K V Rolston, D H Ho, B LeBlanc, et al.
The Journal of Biological Chemistry
|
June 20, 1998
A binding site for heparin in the apple 3 domain of factor XI
D H Ho, K Badellino, F A Baglia, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 117) with videos related to
Sort By:
Page
of 12
Bibliotheca Haematologica
|
January 1, 1973
Pharmacologic and cytokinetic studies of arabinosyl cytosine
E Frei, D H Ho, G P Bodey, et al.
Cancer Chemotherapy Reports
|
December 1, 1971
Distribution and mechanism of clearance of L-asparaginase (NSC-109229)
D H Ho, C J Carter, B Thetford, et al.
European Journal of Clinical Microbiology
|
August 1, 1986
Activity of newer antimicrobial agents against Aeromonas hydrophila
K V Rolston, D H Ho, B LeBlanc, et al.
Cancer Research
|
February 1, 1970
L-asparagine requirement and the effect of L-asparaginase on the normal and leukemic human bone marrow
D H Ho, J P Whitecar, J K Luce, et al.
The Journal of Antimicrobial Chemotherapy
|
July 1, 1990
In-vitro activity of PD 117 596, a new quinolone, against bacterial isolates from cancer patients
K V Rolston, B LeBlanc, D H Ho, et al.
Anticancer Research
|
July 1, 1986
Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate
D H Ho, L Townsend, M A Luna, et al.
Cancer Chemotherapy Reports
|
February 1, 1971
Azotomycin (NSC-56654): biologic fate in mice and man
R F Pittillo, C Woolley, R W Brockman, et al.
Chemotherapy
|
January 1, 1987
In vitro evaluation of difloxacin (A-56619), A-56620, and other 4-quinolones against isolates from cancer patients
K V Rolston, D H Ho, B LeBlanc, et al.
Antimicrobial Agents and Chemotherapy
|
January 1, 1987
In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients
K V Rolston, D H Ho, B LeBlanc, et al.
The Journal of Biological Chemistry
|
June 20, 1998
A binding site for heparin in the apple 3 domain of factor XI
D H Ho, K Badellino, F A Baglia, et al.
Page
of 12